General Information
Revision date
2021-07-16
Product name
ZENTEL TABLETS 200 MG
Product Synonyms
ALBENZA 200 MG TABLETS * ESKAZOLE TABLETS 200 MG * TAFLAZELPAR TABLETS * エエエエ
1.2.2. Uses advised against
No other uses are advised
Emergency telephone
+1-612-221-3999, Ext 221
Icons in SDS
Company Information
company name
GlaxoSmithKline
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H332, H360, H372, H400, H410
Hazard statements
Code
Statements
H332
Harmful if inhaled
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, inhalation Category 4 Reproductive toxicity Category 1B Specific target organ toxicity following Category 1 repeated exposure
Environmental hazards
Hazardous to the aquatic environment, acute Category 1 Hazardous to the aquatic environment, Category 1
Signal word
Danger
Hazard statements
H332 Harmful if inhaled. H360 May damage fertility or the unborn child. H372 Causes damage to organs through prolonged or repeated exposure. H400 Very toxic to aquatic life. H410 Very toxic to aquatic life with long lasting effects.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P261 Avoid breathing dust. P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P271 Use only outdoors or in a well-ventilated area. P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/face protection.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P308 + P313 IF exposed or concerned: Get medical advice/attention. P391 Collect spillage.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
19 % of the mixture consists of component(s) of unknown acute oral toxicity. 100 % of the mixture consists of component(s) of unknown acute dermal toxicity. 70 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 71 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. National/local information Not available
